BA$201.18

BA's income statement reveals highly volatile performance. Revenue growth fluctuated significantly, peaking at 34.5% in FY25 after a sharp decline in FY24. Gross and operating margins were inconsistent, turning negative in FY24 before recovering somewhat in FY25, indicating an inability to consistently translate top-line growth to bottom-line profitability. A substantial "Other Non-Operating Income (Expense)" spike in FY25, combined with a large negative "Other Operating Expenses" in the same year, suggests significant one-off events influencing net income, making durable earnings power difficult to assess. Assuming BA operates in a capital-intensive manufacturing sector, these swings are concerning. Key risks include the extreme volatility in operating expenses and non-operating items, along with the dramatic dip in FY24 profitability, which raise flags about the company's underlying operational stability and earnings quality. The recovery in FY25 is heavily influenced by these unusual items.

BA's balance sheet exhibits mixed signals regarding its health. Current assets have shown growth from $108,666M in FY2021 to $128,459M in FY2025, while total current liabilities also increased significantly from $81,992M to $108,115M over the same period, suggesting a consistent need for working capital. Total liabilities have steadily risen, indicating an increasing leverage, although total assets have also grown, mitigating some solvency concerns. A notable development is the shift in shareholders' equity from negative territory (e.g., -$14,999M in FY2021) to a positive $5,457M in FY2025, marking an improvement in the equity base. However, the company continues to carry substantial total debt of $54,098M in FY2025, partially offset by a growing cash position. The overall structure reflects an industry where significant upfront investment and long production cycles are common, making inventory and unearned revenue substantial components of the balance sheet. The increase in goodwill in FY2025 to $17,275M from $8,084M in FY2024 warrants attention for potential acquisition activity.

BA's cash flow statement reveals significant volatility and concerning trends over the last five fiscal years. Operating Cash Flow (CFO) has been highly inconsistent, swinging from negative in FY2021 (-$3,416M) to positive highs in FY2023 ($5,960M), only to plummet to a substantial negative in FY2024 (-$12,080M) before a modest recovery in FY2025 ($1,065M). This instability, coupled with consistently high capital expenditures, has resulted in a predominantly negative Free Cash Flow (FCF), including a sharp decline to -$14,310M in FY2024 and -$1,877M in FY2025. While financing activities have occasionally provided significant cash injections, particularly in FY2024 due to large debt issuance and common stock issuance, this reliance suggests underlying operational challenges. The substantial swings in working capital accounts further underscore a lack of consistency. Overall, BA demonstrates weak and unpredictable cash generation, raising concerns about its ability to self-fund operations and future growth.

BA is a non-financial company experiencing significant challenges. Its liquidity, as indicated by the quick ratio and current ratio, has remained consistently low, suggesting potential difficulties in meeting short-term obligations. Leverage ratios like Debt/Equity show extreme volatility, moving from negative to highly positive, indicating an unstable capital structure. Efficiency metrics, such as asset turnover and inventory turnover, have shown some improvement over the period but remain moderate. Profitability and returns are a major concern, with highly negative and fluctuating ROE and ROA for most of the periods, turning positive but low in the latest years. Overall, the company's financial health presents a weak picture, reflecting inconsistent performance across key areas.

Boeing's financial trajectory shows a significant turnaround from historical losses to a projected growth phase. Revenue experienced a notable dip in FY 2024 with a 14.5% contraction, but this is followed by a strong recovery, projecting 34.5% growth in FY 2025 and continued double-digit growth through FY 2027. EPS, after several years of negative figures, is estimated to turn positive in FY 2025 and accelerate significantly by FY 2027. The high Forward P/E in FY 2026 reflects initial earnings volatility but normalizes to a more reasonable level in FY 2027 as earnings stabilize and grow. Analyst sentiment is consistently strong, with a 'Strong Buy' consensus across 19 analysts and a median price target of $270. The recommendation trend has remained stable, indicating high confidence in the company's recovery and future prospects.